MetaADEDB 2.0 @ LMMD
Sitagliptin phosphate monohydrate
(GQPYTJVDPQTBQC-KLQYNRQASA-N)
Structure
SMILES
OP(=O)(O)O.N[C@H](Cc1cc(F)c(cc1F)F)CC(=O)N1CCn2c(C1)nnc2C(F)(F)F.O
Molecular Formula:
C16H20F6N5O6P
Molecular Weight:
523.324
Log P:
1.6618
Hydrogen Bond Acceptor:
11
Hydrogen Bond Donor:
5
TPSA:
173.84
CAS Number(s):
654671-77-9
Synonym(s)
1.
Sitagliptin phosphate monohydrate
External Link(s)
PubChem Compound11591741
CHEMBLCHEMBL1201174
KEGGdr:D06645
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Seronegative arthritisFAERS: 9US FAERS
2OverdoseFAERS: 3US FAERS
3Aspartate Aminotransferase IncreasedFAERS: 2US FAERS
4Blood creatine phosphokinase increasedFAERS: 2US FAERS
5Cerebral InfarctionFAERS: 2US FAERS
6Diabetic RetinopathyFAERS: 2US FAERS
7Drug prescribing errorFAERS: 2US FAERS
8Erythema MultiformeFAERS: 2US FAERS
9Intestinal ObstructionFAERS: 2US FAERS
10PemphigusFAERS: 2US FAERS
11Pneumatosis intestinalisFAERS: 2US FAERS
12Portal venous gasFAERS: 2US FAERS
13AcromegalyFAERS: 1US FAERS
14Alanine Aminotransferase IncreasedFAERS: 1US FAERS
15Altered state of consciousnessFAERS: 1US FAERS
16Angina PectorisFAERS: 1US FAERS
17AppendicitisFAERS: 1US FAERS
18Autoimmune PancreatitisFAERS: 1US FAERS
19Blood glucose decreasedFAERS: 1US FAERS
20Blood glucose increasedFAERS: 1US FAERS
21Blood lactate dehydrogenase increasedFAERS: 1US FAERS
22Completed SuicideFAERS: 1US FAERS
23Contralateral breast cancerFAERS: 1US FAERS
24DeafnessFAERS: 1US FAERS
25Device dislocationFAERS: 1US FAERS
26DizzinessFAERS: 1US FAERS
27Drug abuseFAERS: 1US FAERS
28Drug administration errorFAERS: 1US FAERS
29Eosinophilic PneumoniaFAERS: 1US FAERS
30FolliculitisFAERS: 1US FAERS
31Gamma-Glutamyltransferase IncreasedFAERS: 1US FAERS
32HepatitisFAERS: 1US FAERS
33IleusFAERS: 1US FAERS
34MalaiseFAERS: 1US FAERS
35Myoglobin blood increasedFAERS: 1US FAERS
36No adverse eventFAERS: 1US FAERS
37Pancreatic CystFAERS: 1US FAERS
38PneumoniaFAERS: 1US FAERS
39PolydipsiaFAERS: 1US FAERS
40PolyuriaFAERS: 1US FAERS
41Product prescribing errorFAERS: 1US FAERS
42Psychiatric symptomFAERS: 1US FAERS
43Pulmonary FibrosisFAERS: 1US FAERS
44Respiratory DepressionFAERS: 1US FAERS
45Respiratory FailureFAERS: 1US FAERS
46RhabdomyolysisFAERS: 1US FAERS
47SarcoidosisFAERS: 1US FAERS
48ThirstFAERS: 1US FAERS
49Transaminases increasedFAERS: 1US FAERS
50Wrong technique in product usage processFAERS: 1US FAERS
51jaundiceFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.